Ovarian Resistance Syndrome vs PCOS: A Rare Condition That Mimics It

What is ovarian resistance syndrome?

Ovarian resistance syndrome is a rare disorder where the ovaries stop responding to the hormones that should trigger ovulation, despite having a normal or usual supply of follicles left to work with. The clinical picture is specific: primary or secondary amenorrhea, elevated FSH and LH (because the pituitary is trying harder to get a response), low estrogen (because the follicles aren’t answering), yet a normal karyotype and a follicle count on ultrasound that looks unremarkable — not depleted, just unresponsive. It was first documented as a distinct entity in a 1969 case report describing “a new syndrome of amenorrhoea in association with hypergonadotropism and apparently normal ovarian follicular apparatus,” and a 2022 review of the last five decades of case literature still describes its underlying mechanism as poorly understood, with no universally effective treatment established. For where this sits inside a full work-up, see how PCOS itself is actually diagnosed — since the two get confused with each other often enough that ruling one out usually means testing for the other.

Where do the names “resistant ovary syndrome” and “Savage syndrome” come from?

The condition is named “Savage syndrome” after the surname of the patient described in that original 1969 case report — a naming convention common in rare-disease history, not a description of what the condition does. “Resistant ovary syndrome” describes the mechanism directly: the ovary resists the pituitary’s gonadotropin signal rather than running out of follicles to respond with it. Both names refer to the same rare condition, and you may also see it written as “gonadotropin- resistant ovary syndrome” in more recent case reports.

How is ovarian resistance syndrome different from PCOS?

The gonadotropin pattern runs in opposite directions in the two conditions: ovarian resistance syndrome produces elevated FSH and LH with low estrogen, while PCOS typically presents with normal or low FSH, often a raised LH:FSH ratio, and normal-to-high estrogen. PCOS also features androgen excess and, on ultrasound, an excess follicle count consistent with the polycystic ovarian morphology defined in the Rotterdam criteria — a pattern that helps define which of the four real Rotterdam phenotypes a person has. Ovarian resistance syndrome shows none of that: no androgen excess, and a follicle count that is unremarkable rather than excessive. The two conditions can both cause irregular or absent periods in a woman with a “normal-looking” ovarian reserve, which is exactly why the distinction gets missed — but the hormone panel that separates PCOS from hypothalamic amenorrhea and lean PCOS presentations also separates PCOS from ovarian resistance syndrome, just in the opposite direction on FSH and LH.

Is ovarian resistance syndrome the same as premature ovarian insufficiency?

No — the two conditions share an elevated-FSH, low-estrogen, missed-period picture, but they differ on the one measurement that changes what treatment can offer: ovarian reserve. In premature ovarian insufficiency, the follicle supply is genuinely depleted, so there are fewer eggs left to stimulate regardless of protocol. In ovarian resistance syndrome, the follicles are still there in usual numbers — they simply aren’t responding to the gonadotropin signal reaching them, which is a mechanical or receptor-level problem rather than a supply problem. That distinction is why some women labeled with premature ovarian insufficiency who are later confirmed to have a normal follicle count on ultrasound get re-classified as ovarian resistance syndrome instead, with a different fertility conversation as a result.

What causes ovarian resistance syndrome?

A specific inactivating mutation in the follicle-stimulating hormone receptor gene was identified as the cause in a Finnish population in 1995, explaining hereditary cases within that founder group, and separate case reports from two Chinese families in 2017 identified novel mutations in the same gene causing the condition. But genetics doesn’t explain every case: a UK study that screened women with resistant ovary syndrome for mutations in that same FSH receptor gene found none at all, indicating the genetic mutation identified in Finland is not a universal cause and that at least some cases arise through a different, still poorly defined mechanism — possibly autoimmune activity against the ovary or the receptor itself, though that remains an area of active, unsettled research rather than an established mechanism.

Can you still get pregnant with ovarian resistance syndrome?

Yes, in at least some documented cases — a 2024 case report describes two women with confirmed ovarian resistance syndrome who achieved successful live births through conventional IVF, using a stimulation protocol that combined three cycles of hormone-replacement pretreatment with pituitary down-regulation before ovarian stimulation. That protocol produced multiple mature eggs and viable embryos in both cases, where standard stimulation approaches had previously failed. The honest caveat: this evidence exists as individual case reports, not a large trial, and the same 2024 paper states plainly that no universally accepted stimulation protocol yet exists for this condition — what worked for those two women is a promising approach, not a guaranteed one, and outcomes likely still depend heavily on the individual cause behind a given case. That’s a much thinner evidence base than exists for conception rates in PCOS itself, which is drawn from far larger studies precisely because ovarian resistance syndrome is so rare.

Who this will not help

This will not resolve on its own the way a temporarily irregular cycle might — ovarian resistance syndrome does not respond to the lifestyle or weight-focused approaches that help some PCOS presentations, because the mechanism is a receptor-level signalling problem, not a metabolic or androgen-driven one. It also isn’t something a standard PCOS work-up will catch by accident: a clinician looking for polycystic ovarian morphology and androgen excess is looking for the opposite hormone pattern from the one this condition produces, so it has to be specifically considered and tested for once premature ovarian insufficiency and PCOS have both been ruled out. And because confirmed cases remain small in number, no clinician can currently promise a specific pregnancy rate or timeline — only that pregnancy has been documented as possible in cases that were properly diagnosed and treated.

Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Ovarian resistance syndrome is a separate condition from PCOS/PMOS entirely, and the rename doesn’t change anything about it — it’s mentioned here only because the two conditions are commonly confused with each other during work-up.

Your next step

If your bloodwork shows high FSH and LH with low estrogen, ask your clinician directly whether your ultrasound follicle count is being read as depleted (pointing toward premature ovarian insufficiency) or normal (pointing toward ovarian resistance syndrome instead) — that single distinction changes which fertility options are worth discussing next.